Hosted on MSN13m
Elevance Health's Q4 Earnings Beat Estimates on Rising Premiums
Elevance Health, Inc. ELV reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7% ...
Trump scrapped a proposed $2 drug program for seniors. But why?
President Donald Trump rolled back a Biden administration executive order aimed at lowering prescription drug prices, including an effort to make more generic drugs available to Medicare patients for ...